Literature DB >> 11703202

Is preeclampsia an infectious disease?

L I Trogstad1, A Eskild, A L Bruu, S Jeansson, P A Jenum.   

Abstract

BACKGROUND: Studies have suggested a strong paternal factor in the etiology of preeclampsia. If preeclampsia is caused by an infectious agent transmitted by the woman's partner, seronegative women who may experience primary infection in pregnancy should be at increased risk of preeclampsia as compared to previously infected women. The aim of this study was to assess the impact of being seronegative for some viruses transmitted by close contact on the risk of developing preeclampsia.
METHODS: Nine hundred and seventy-eight women were randomly drawn from a basic study population of 35,940 pregnant women in Norway. A serum sample drawn at the first antenatal visit was analyzed for specific IgG antibodies against herpes simplex virus type-2, cytomegalovirus and Epstein-Barr virus. For comparison, antibody status against Toxoplasma gondii was also assessed. Information on preeclampsia in pregnancy was obtained through linkage to the Medical Birth Registry of Norway.
RESULTS: Thirty-three (3%) women developed preeclampsia. The risk of developing preeclampsia seemed to be increased for women who were seronegative for the viruses studied. Seronegativity for Toxoplasma gondii did not show such a pattern.
INTERPRETATION: Women who are seronegative for antibodies against viral agents transmitted through close contact seem more likely to develop preeclampsia. This finding indicates that women who are seronegative to such agents may acquire primary infection in pregnancy, and subsequently be at increased risk of preeclampsia. This hypothesis could represent a new approach to the causes of preeclampsia, and encourage search for yet unidentified microbes as a possible causal factor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11703202     DOI: 10.1034/j.1600-0412.2001.801112.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  16 in total

1.  Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.

Authors:  Ossama M Reslan; Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-10-01

Review 2.  Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy.

Authors:  Sajjadh M J Ali; Raouf A Khalil
Journal:  Expert Opin Ther Targets       Date:  2015-08-17       Impact factor: 6.902

3.  Prenatal Chlamydia trachomatis infection increases the risk of preeclampsia.

Authors:  Catherine L Haggerty; Mark A Klebanoff; Inge Panum; Soren A Uldum; Debra C Bass; Jorn Olsen; James M Roberts; Roberta B Ness
Journal:  Pregnancy Hypertens       Date:  2013-07-01       Impact factor: 2.899

4.  Antigen Analysis of Pre-Eclamptic Plasma Antibodies Using Escherichia Coli Proteome Chips.

Authors:  Te-Yao Hsu; Jyun-Mu Lin; Mai-Huong T Nguyen; Feng-Hsiang Chung; Ching-Chang Tsai; Hsin-Hsin Cheng; Yun-Ju Lai; Hsuan-Ning Hung; Chien-Sheng Chen
Journal:  Mol Cell Proteomics       Date:  2017-12-28       Impact factor: 5.911

Review 5.  Human infectious diseases and risk of preeclampsia: an updated review of the literature.

Authors:  Malihe Nourollahpour Shiadeh; Zahra Behboodi Moghadam; Ishag Adam; Vafa Saber; Maryam Bagheri; Ali Rostami
Journal:  Infection       Date:  2017-06-02       Impact factor: 3.553

Review 6.  Animal Models of Preeclampsia: Mechanistic Insights and Promising Therapeutics.

Authors:  Erin B Taylor; Eric M George
Journal:  Endocrinology       Date:  2022-08-01       Impact factor: 5.051

Review 7.  Association between maternal infections and preeclampsia: a systematic review of epidemiologic studies.

Authors:  Luis O Rustveld; Sheryl F Kelsey; Ravi Sharma
Journal:  Matern Child Health J       Date:  2007-06-19

8.  Low incidence of hypertensive disorders of pregnancy in women treated with spiramycin for toxoplasma infection.

Authors:  T Todros; P Verdiglione; G Oggè; D Paladini; P Vergani; S Cardaropoli
Journal:  Br J Clin Pharmacol       Date:  2006-03       Impact factor: 4.335

Review 9.  Seminal shedding of human herpesviruses.

Authors:  Maja D Kaspersen; Per Höllsberg
Journal:  Virol J       Date:  2013-07-08       Impact factor: 4.099

10.  Placental Toll-like receptor 3 and Toll-like receptor 7/8 activation contributes to preeclampsia in humans and mice.

Authors:  Piyali Chatterjee; Laura E Weaver; Karen M Doersch; Shelley E Kopriva; Valorie L Chiasson; Samantha J Allen; Ajay M Narayanan; Kristina J Young; Kathleen A Jones; Thomas J Kuehl; Brett M Mitchell
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.